How Much Did Delsys Raise?
Funding & Key Investors

Delsys has solidified its position as a critical player in the biosignal measurement sector, securing a total capital infusion of $1.6M. This financial milestone, bolstered by a recent strategic investment of $582K, underscores the company's sustained growth trajectory and its essential role in the global neuromuscular research and clinical diagnostics landscape. By leveraging this influx of capital, Delsys continues to refine its sophisticated suite of sensor technologies, ensuring that its enterprise-level operations remain at the forefront of physiological data acquisition and analysis.

What is Delsys?

Delsys
ManufacturingTest & Measurement EquipmentMedical Devices & Equipment

Delsys operates at the intersection of biomedical engineering and human performance, specializing in the design, manufacture, and marketing of high-precision sensors that detect and quantify electrical signals generated during muscle contraction. The company's extensive product portfolio—which includes EKG sensors, accelerometers, foot sensors, and goniometers—serves a diverse global clientele spanning over 1200 research and clinical centers. By providing quantitative insights into the neuromuscular system, Delsys technology is instrumental in laboratory research, clinical rehabilitation, sports performance optimization, and ergonomic assessment. Its market position is defined by a commitment to high-fidelity data, enabling professionals to monitor neuromuscular health, track recovery progress, and enhance human-machine interaction through advanced biofeedback mechanisms.

How much funding has Delsys raised?

Delsys has raised a total of $1.6M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$582K

Debt (2020): $1M with participation from PPP

Debt (2021): $582K led by PPP

Key Investors in Delsys

PPP

Public-Private Partnership

What's next for Delsys?

With the recent capital injection, Delsys is well-positioned to scale its enterprise-level infrastructure and expand its footprint in the rapidly evolving digital health market. The strategic focus will likely shift toward integrating artificial intelligence with existing biosignal data streams to provide predictive analytics for neuromuscular injury prevention and rehabilitation. Furthermore, the company is expected to deepen its penetration into the sports science and ergonomics sectors, where the demand for non-invasive, real-time physiological monitoring is accelerating. By maintaining its rigorous standards for sensor accuracy and reliability, Delsys is poised to capitalize on the increasing global emphasis on personalized medicine and human performance optimization, ensuring long-term value creation for its stakeholders and the broader scientific community.

See full Delsys company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Automotive PartsManufacturing
ManufacturingTextiles & ApparelApparel & Accessories RetailRetail
ElectronicsManufacturing
ManufacturingMedical Devices & EquipmentDrug Stores & PharmaciesRetail

Frequently Asked Questions Regarding Delsys Financial Insights

What are the most recent funding rounds that Delsys has completed, and what were the funding rounds?
Delsys has recently completed 2 funding rounds: Debt on Mar 25, 2021, Debt on Apr 15, 2020.
What is the total amount of funding Delsys has raised to date?
Delsys has raised a total of $1.6M in funding to date.
How many funding rounds has Delsys completed?
Delsys has completed 2 funding rounds.
How much funding did Delsys raise in its most recent funding round?
Delsys raised $582K in its most recent funding round.
Who are the lead investors in Delsys's latest funding round?
The lead investor in Delsys's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Delsys's history?
The largest funding round in Delsys's history was $1M.
See more information about Delsys